AIDS Action Urges Everyone To Help End The AIDS Epidemic By Being Part Of The Search For An HIV Vaccine

Twenty-six years into the
AIDS epidemic, someone is newly infected with HIV every 13 minutes in the
U.S. On Sunday, May 18, HIV Vaccine Awareness Day, AIDS Action, one of five
national partners in the National Institute of Allergy and Infectious
Disease (NIAID) HIV Vaccine Research Education Initiative, urges everyone
to help end the AIDS epidemic by participating in the search for an HIV
Vaccine. We also thank the numerous volunteers, community educators,
scientists and advocates for their efforts to further HIV vaccine research.


AIDS Action's support for continued and increased investment in HIV
vaccine research is unwavering. Basic HIV vaccine research must remain one
of the many prevention strategies being pursued at a national level. We
will continue to advocate for HIV vaccine research here in Washington, DC
and raise awareness of and support for HIV vaccine research across the
country.



The best long-term hope for controlling the AIDS epidemic is the
development of safe, effective and affordable HIV vaccines. Historically,
vaccines have been the most powerful weapon against diseases like polio,
measles and Hepatitis B. In fact, no major viral epidemic has been defeated
without one.



Vaccine research is a difficult, complicated and iterative process that
takes many years. It took 47 years to develop a vaccine for polio, and 42
for measles. This past September, the phase II Merck Step Trial was halted
due to ineffectiveness, raising a storm of scientific and media inquiry.
While the results were disappointing, the Step trial itself and its safety
mechanisms were successfully implemented. The failure of one vaccine
candidate does not signify the failure of all HIV vaccine research. This
setback, as have others, may be a stepping stone to future success.



AIDS Action is committed to increase awareness of the need for an HIV
vaccine, improve the public's knowledge of vaccine research and create
support for current and future HIV vaccine trials. We must focus on
increasing awareness among African Americans, Latinos, women and men who
have sex with men. The epidemic is taking an increasingly devastating toll
on these disproportionately affected populations, yet African Americans,
Latinos, women, and men who have sex with men are largely underrepresented
in HIV vaccine research clinical trials. A large HIV vaccine trial will
require thousands of participants of all races/ethnicities, genders and
socioeconomic backgrounds to ensure that the vaccine works in all
populations. Therefore, community support is essential in efforts to break
down stigma and myths about HIV vaccine research.



As a National Partner, AIDS Action will work to establish leadership
and support for HIV vaccine research and its clinical trials. Through its
membership network of AIDS service organizations, health departments,
health educators, and community-based organizations across the country,
AIDS Action is perfectly poised to increase HIV vaccine awareness among key
influencers and community and national leaders.



So, here is what you can do to help. Find information about HIV vaccine
research efforts, Talk about HIV vaccine research with your family and
friends, support a trial volunteer, or contact your local trial site to
become a volunteer or joining a community advisory board. We encourage
everyone to become involved in HIV Vaccine Awareness Day.



Learn more about events in your area, how you can help, and the facts
about HIV vaccine research at bethegeneration and
aidsaction.


AIDS Action

aidsaction

Our Recommendations:


•   Purchase Differin Online
•   Buy Quick-Detox Online No Prescription
•   Purchase Inderal Online
•   Buy Cheap Allegra